pharmaceutical compositions, methods of treating obesity and related metabolic disorders, mammalian body mass reduction, mammalian body mass growth, mammalian food consumption, psychoactive substance addiction patient treatment, substance addiction treatment psychoactive drug and activated-potentiated use of human cannabinoid receptor antibody.

摘要

pharmaceutical compositions, methods of treating obesity and related metabolic disorders, reduction of mammalian body mass, growth of mammalian body mass, consumption of food in mammal, treatment of psychoactive substance addiction, substance addiction patient psychoactive drug and activated-potentiated use of human cannabinoid receptor antibody. The present invention provides pharmaceutical compositions comprising an activated potentiated form of an antibody to the human cannabinoid receptor and use in the treatment of obesity and related metabolic disorders. The present invention also provides pharmaceutical compositions comprising an activated potentiated form of a human cannabinoid receptor antibody and an activated potentiated form of an s-100 protein antibody for use in the treatment of addiction to psychoactive substances. The present invention provides a method for the treatment of obesity and related metabolic disorders and substance abuse.